Vaccine Storage and Packaging Market Report 2026

The vaccine storage and packaging market size has grown strongly in recent years. It will grow from $23.87 billion in 2025 to $25.7 billion in 2026 at a compound annual growth rate (CAGR) of 7.7%. The growth in the historic period can be attributed to expansion of global immunization programs, growth in pharmaceutical cold storage infrastructure, increased production of temperature-sensitive vaccines, adoption of standardized packaging formats, improvements in logistics networks.

The vaccine storage and packaging market size is expected to see strong growth in the next few years. It will grow to $34.12 billion in 2030 at a compound annual growth rate (CAGR) of 7.3%. The growth in the forecast period can be attributed to growing development of mRNA vaccines, rising investments in cold chain digitization, expansion of global vaccine distribution networks, increasing focus on sustainability in packaging, technological advancements in storage equipment. Major trends in the forecast period include increasing deployment of cold chain monitoring systems, rising use of smart temperature-controlled packaging, growing demand for ultra-low temperature storage, expansion of sustainable packaging materials, enhanced focus on vaccine traceability.

The rise in vaccine production is expected to drive the growth of the vaccine storage and packaging market going forward. Vaccines are formulations that stimulate the immune system to develop protection against specific diseases by mimicking the body’s natural response to infection. The increase in vaccine production is fueled by the growing prevalence of infectious diseases, which raises the global demand for preventive healthcare measures to control outbreaks and protect public health. Vaccine production necessitates effective storage and packaging solutions, as vaccines are highly sensitive to temperature fluctuations and contamination, requiring specialized packaging and cold chain logistics to maintain their safety and efficacy during handling and distribution. For instance, in February 2025, according to the World Health Organization, a Switzerland-based intergovernmental organization, the global production capacity for seasonal influenza vaccines was estimated at 1.53 billion doses annually. Therefore, the rise in vaccine production is propelling the growth of the vaccine storage and packaging market.

Major companies operating in the vaccine storage and packaging market are focusing on developing advanced products, such as direct-to-fill technology, to optimize vaccine manufacturing and minimize contamination risks. The direct-to-fill method reduces handling time, lowers contamination risk, and helps preserve the stability and integrity of vaccines, ensuring more efficient and safer production. For instance, in October 2024, Nipro PharmaPackaging, a Belgium-based medical equipment manufacturer, launched D2 (Direct-to-Fill) glass vials, a ready-to-use (RTU) solution featuring EZ-fill technology. These vials are pre-washed, depyrogenated, sterilized, and packaged for direct integration into aseptic fill-finish lines. Designed for compatibility with a range of machines, D2F vials improve operational efficiency, reduce breakage and defects, and offer enhanced durability and cost-effectiveness through their nest-and-tub packaging system.

In December 2024, Gerresheimer, a Germany-based pharmaceutical company, acquired Blitz LuxCo Sarl for an undisclosed amount. This acquisition allows Gerresheimer to expand its portfolio with advanced and reliable packaging solutions, including customizable, tamper-proof, and temperature-controlled containers, thereby strengthening its position in the growing vaccine storage and packaging market. Blitz LuxCo Sarl is an Italy-based manufacturer of vaccine packaging solutions, including glass and plastic containers.

Major companies operating in the vaccine storage and packaging market are McKesson Corporation, AmerisourceBergen Corporation, DHL International GmbH, United Parcel Service Inc., FedEx Corporation, PHCbi Panasonic Healthcare Co. Ltd., Thermo Fisher Scientific Inc., DB Schenker, Corning Incorporated, STERIS plc, NIPRO Corporation, AptarGroup Inc., Schott AG, Gerresheimer AG, Thermo King Corporation, Lineage Inc., Stevanato Group S.p.A., Eppendorf SE, Haier Biomedical, Cole-Parmer Instrument Company LLC, DWK Life Sciences, B Medical Systems, Helmer Scientific Inc., Arctiko A/S, American Biotech Supply LLC, The Cool Ice Box Company Ltd.

North America was the largest region in the vaccine storage and packaging market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the vaccine storage and packaging market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the vaccine storage and packaging market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs are impacting the vaccine storage and packaging market by increasing costs of imported refrigeration units, insulation materials, glass vials, sensors, and specialized packaging components. Pharma and biotech companies in North America and Europe are most affected due to reliance on imported cold chain equipment, while Asia-Pacific faces higher costs for export-oriented packaging production. These tariffs are increasing operational costs and capital expenditure requirements. However, they are also driving domestic manufacturing of cold storage systems, regional packaging innovation, and local supply chain development to ensure long-term vaccine security.

The vaccine storage and packaging market research report is one of a series of new reports that provides vaccine storage and packaging market statistics, including vaccine storage and packaging industry global market size, regional shares, competitors with a vaccine storage and packaging market share, detailed vaccine storage and packaging market segments, market trends and opportunities, and any further data you may need to thrive in the vaccine storage and packaging industry. This vaccine storage and packaging market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Vaccine storage and packaging refer to the processes and systems used to maintain the safety, potency, and effectiveness of vaccines from production to administration. Storage involves keeping vaccines within specific temperature ranges, typically between +2°C and +8°C for refrigerated vaccines or below -15°C for frozen vaccines, using cold chain equipment such as refrigerators and insulated containers. Packaging includes the materials and containers used to protect vaccines during handling and transport, such as vials, syringes, boxes, and insulated shipping materials.

The primary types of vaccine storage and packaging are vaccine storage and vaccine packaging. Vaccine storage ensures vaccines are maintained at specific temperatures and conditions to preserve safety, potency, and effectiveness until administration. Vaccine packaging uses materials such as plastic, glass, paper, and paperboard for different vaccine types, including messenger RNA (mRNA) vaccines, DNA vaccines, protein-based vaccines, and viral vector vaccines. These solutions are applied for both human and animal vaccines and are utilized by end users such as pharmaceutical and biotechnology companies, diagnostic centers, clinical research organizations, and other healthcare facilities.

The vaccine storage and packaging market consists of revenues earned by entities by providing services such as cold chain logistics services, packaging services, emergency and contingency services, and inventory and supply chain management. The market value includes the value of related goods sold by the service provider or included within the service offering. The vaccine storage and packaging market also includes sales of insulated boxes, ice packs and thermal insulation and packaging materials. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.